Solasia Pharma Reports Large Exercise of

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on January 8, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Solasia Pharma Reports Large Exercise of Warrant Options

Source disclosure: January 08, 2026 Solasia Pharma K.K. [4597.T] TOKYO, Jan 08 (Pulse News Wire) – Solasia Pharma K.K. (4597.T) reported large-scale exercise of warrant options during the period from April 09, 2025, to January 08, 2026. According to the report, the company issued warrant options with price adjustment clauses on April 09, 2025. During the mentioned period, a total of 55,000 warrant options were exercised, representing 10.11% percent of the total issuance. As of the e